NLRP3 and atherosclerosis: The initiation of NLRP3 inflammasome in endothelial cells under pathophysiological conditions may exacerbate endothelial weakness, prompting hypertension, obesity, diabetes, neuroinflammation, retinopathy, atherosclerosis, cerebrovascular accident and malignancy.